The ADRB3 genotype and weight status (normal-weight or overweight/obese) tended to have interactive effects on the risk of NAFLD (p = 0.08); thus, multivariable analyses were performed separately in normal-weight and overweight/obese subjects. The gene discussed is ADRB3; the disease is metabolic dysfunction-associated steatotic liver disease.